Zinc in Potatoes Study
ZIP
Do Zinc Fortified Potatoes Improve Zinc and Health Status?
1 other identifier
interventional
36
1 country
1
Brief Summary
Zinc is important in biology and allows the proper function of proteins in living organisms. Severe zinc deficiency in animals and humans over long periods of time can therefore cause adverse effects. In the UK, the zinc status of most people is adequate, but about 20% of the population, especially adolescents in deprived communities and vegetarians/vegans, are likely marginally zinc deficient. Because potatoes are a favoured food in adolescents and vegetarians/vegans, the investigators have improved the zinc content of Saxon potatoes by biofortification, which involves spraying potato plant leaves with zinc salts. The potato zinc concentration is about three times the level in unfortified potatoes of the same variety. This level of zinc can boost the zinc intake of people who are marginally zinc deficient so that they become zinc adequate. Indeed, in rat studies, the investigators have shown that addition of some zinc-biofortified potato to a low zinc diet improves the zinc and health status of the animals. In the present study, the investigators propose to investigate whether the potato biofortification can improve the zinc and health status of volunteers. Because most of the volunteers (healthy adult men and women after the menopause) might have normal or variable zinc status at recruitment, it might not be possible to see the benefits of the potato diets and therefore, the investigators shall reduce the zinc intake of all 45 participants to 1 mg Zn/d for a period of two weeks prior to feeding 15 randomly selected individuals the biofortified potato diets (4 mg Zn/d) for two weeks. Zinc and health status will be measured by blood tests before and after zinc depletion and after feeding the potato diets. Results will be compared with data from 15 volunteers eating unfortified potato diets with a daily placebo and 15 volunteers consuming the unfortified potato diets with a zinc supplement (18 mg/d) as a positive control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 24, 2019
CompletedFirst Submitted
Initial submission to the registry
December 15, 2021
CompletedFirst Posted
Study publicly available on registry
January 10, 2022
CompletedJanuary 10, 2022
January 1, 2022
2.7 years
December 15, 2021
January 6, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Plasma Zinc status
Plasma zinc levels will be measured using ICP-MS
4 weeks
Zinc status
The Exchangeable Zinc Pool size (EZP) will be assessed by the analysis of the Zn stable isotopes excreted in the urine by ICP-MS/MS.
4 weeks
Secondary Outcomes (2)
Eye Electrophysiology
4 weeks
Thromboelastography (efficiency of blood clotting)
4 weeks
Study Arms (3)
Unfortified potato plus placebo
PLACEBO COMPARATORVolunteers given potato with no fortified zinc and a placebo
Zinc Biofortified potato plus placebo
ACTIVE COMPARATORVolunteers given potato biofortified with zinc and a placebo
Unfortified potato plus zinc supplement
ACTIVE COMPARATORVolunteers given potato with no fortified zinc and a zinc supplement
Interventions
Volunteers will be given 300g of zinc unfortified cooked potato as well as a placebo every day.
Volunteers will be given 300g of cooked potato biofortified with zinc and a placebo every day.
Volunteers will be given 300g of zinc unfortified cooked potato and a zinc supplement containing 18mg of zinc, every day.
Eligibility Criteria
You may qualify if:
- Males aged 18 or over
- Postmenopausal females
- Healthy
- BMI 19-35
You may not qualify if:
- Physical or mental health problems
- Long-term medication
- Smoking
- Alcohol \>20 units/week
- Health supplements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aberdeenlead
- Fight for Sightcollaborator
Study Sites (1)
University of Aberdeen
Aberdeen, AB25 2ZD, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
John H Beattie, PhD
University of Aberdeen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- Computer-based randomisation system
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2021
First Posted
January 10, 2022
Study Start
October 10, 2016
Primary Completion
June 24, 2019
Study Completion
June 24, 2019
Last Updated
January 10, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share